1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. GALECTIN THERAPEUTICS INC

Galectin Therapeutics Inc

XNAS: GALT

Download real time

1.65 0.06 (3.77%)

61.36% Fall from 52W High

388.4K XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
6W
4O
0T
103.6

Market Cap

Below industry Median
-2.3

PE TTM

Negative PE TTM
0.3

PEG TTM

PEG TTM is less than 1
-1.1

Price to Book

Negative Price to Book
-0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Galectin Therapeutics Inc is on 28 Mar 2025 for the purpose of Galectin Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Galectin Therapeutics Inc

The latest disclosure was made by Joel Lewis in Galectin Therapeutics Inc where a trade of 56,420 Common Stock done at an average price of $1.6 was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.57 per share. 03 Mar 2025 56,420 832,592 (1%) 0% 1.6 88,579 Common Stock
Benjamin S. Carson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 65,000 65,000 - - Stock Option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Restricted Stock Unit
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.23 per share. 23 Jan 2025 32,520 10,301,271 (18%) 0% 1.2 40,000 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 91,000 91,000 - - Stock Option (right to buy)
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 84,000 84,000 - - Restricted Stock Unit
Elissa J. Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Richard A. Zordani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Khurram Jamil Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 65,000 65,000 - - Stock Option (right to buy)
Khurram Jamil Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Restricted Stock Unit
Harold H. Shlevin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 60,000 60,000 - - Stock Option (right to buy)
Shlevin H. Harold Director Purchase of securities on an exchange or from another person at price $ 1.16 per share. 30 Dec 2024 6,500 15,206 (0%) 0% 1.2 7,540 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 0.82 per share. 24 Dec 2024 13,469 63,682 (0%) 0% 0.8 11,045 Common Stock
Richard Zordani A. Director Purchase of securities on an exchange or from another person at price $ 0.82 per share. 24 Dec 2024 10,000 42,083 (0%) 0% 0.8 8,164 Common Stock
D. Freeman Kevin Director Purchase of securities on an exchange or from another person at price $ 0.81 per share. 24 Dec 2024 10,000 44,769 (0%) 0% 0.8 8,134 Common Stock
W. Callicutt Jack Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 40,000 47,614 (0%) 0% 0 Common Stock
Jamil Khurram Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.88 per share. 23 Dec 2024 13,654 26,346 (0%) 0% 0.9 12,044 Common Stock
Jamil Khurram Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 40,000 40,000 (0%) 0% 0 Common Stock
W. Jack Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.89 per share. 23 Dec 2024 40,000 7,614 (0%) 0% 0.9 35,492 Common Stock
Callicutt W. Jack Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 40,000 0 - - Restricted Stock Units
Lewis Joel Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 56,000 0 - - Restricted Stock Units
Joel Lewis Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 56,000 953,012 (1%) 0% 0 Common Stock
Khurram Jamil Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2024 40,000 0 - - Restricted Stock Units
Joel Lewis Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.89 per share. 23 Dec 2024 56,000 897,012 (1%) 0% 0.9 49,610 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 2.60 per share. 23 Oct 2024 500 50,213 (0%) 0% 2.6 1,300 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.64 per share. 17 Oct 2024 1,300 34,769 (0%) 0% 2.6 3,432 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.70 per share. 16 Oct 2024 5,000 80,000 (0%) 0% 2.7 13,500 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.70 per share. 16 Oct 2024 5,000 33,469 (0%) 0% 2.7 13,500 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 2.30 per share. 22 Aug 2024 741 30,324 (0%) 0% 2.3 1,704 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 2.30 per share. 22 Aug 2024 1,000 2,000 (0%) 0% 2.3 2,300 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 2.30 per share. 22 Aug 2024 1,759 32,083 (0%) 0% 2.3 4,046 Common Stock
Khurram Jamil Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2024 100,000 100,000 - - Stock Option (right to buy)
Khurram Jamil Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2024 10,000 10,000 - - Restricted Stock Unit
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 2.39 per share. 22 Jul 2024 400 49,713 (0%) 0% 2.4 956 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.38 per share. 20 Jun 2024 2,500 28,469 (0%) 0% 2.4 5,950 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 3.52 per share. 30 Apr 2024 1,000 1,000 (0%) 0% 3.5 3,520 Common Stock
Joel Lewis Director, President and CEO Purchase of securities on an exchange or from another person at price $ 3.39 per share. 24 Apr 2024 1,000 2,000 (0%) 0% 3.4 3,390 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.98 per share. 22 Apr 2024 2,500 25,969 (0%) 0% 3.0 7,450 Common Stock
James C. Czirr Ten Percent Owner Sale of securities on an exchange or to another person at price $ 3.06 per share. 22 Apr 2024 3,677 5,922,207 (10%) 0% 3.1 11,252 Common Stock
James C. Czirr Ten Percent Owner Sale of securities on an exchange or to another person at price $ 3.06 per share. 22 Apr 2024 21,323 5,925,884 (10%) 0% 3.1 65,248 Common Stock
Kevin D. Freeman Director 09 Apr 2024 2,063 18,063 (0%) 0% 0 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.96 per share. 01 Mar 2024 152,584 897,716 (1%) 0% 2.0 299,065 Common Stock
Omenn S. Gilbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Uihlein Richard E. Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.72 per share. 24 Jan 2024 23,256 10,268,751 (18%) 0% 1.7 40,000 Common Stock
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 65,000 65,000 - - Stock Option (right to buy)
Lewis Joel Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 91,000 91,000 - - Stock Option (right to buy)
Eldred Kary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
F. Pol Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 40,000 40,000 - - Restricted Stock Unit
J. Elissa Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
F. Boudes Pol Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 65,000 65,000 - - Stock Option (right to buy)
W. Callicutt Jack Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 40,000 40,000 - - Restricted Stock Unit
Zordani Richard A. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Carson S. Benjamin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Gilbert Amelio F. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 50,000 50,000 - - Stock Option (right to buy)
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 56,000 56,000 - - Restricted Stock Unit
Eldred Kary Director Purchase of securities on an exchange or from another person at price $ 1.79 per share. 16 Jan 2024 500 49,313 (0%) 0% 1.8 893 Common Stock
James C. Czirr Ten Percent Owner Other type of transaction at price $ 6.00 per share. 31 Dec 2023 1,000 762,616 (1%) 0% 6 6,000 Common Stock
James C. Czirr Ten Percent Owner Other type of transaction at price $ 6.00 per share. 31 Dec 2023 1,000 761,616 (1%) 0% 6 6,000 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.66 per share. 29 Dec 2023 11,606 1,042,300 (1%) 0% 1.7 19,266 Common Stock
Lewis Joel Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.60 per share. 15 Dec 2023 12,042 1,030,694 (1%) 0% 1.6 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.95 per share. 30 Nov 2023 9,880 1,018,652 (1%) 0% 2.0 19,266 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.87 per share. 15 Nov 2023 10,303 1,008,772 (1%) 0% 1.9 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.04 per share. 31 Oct 2023 9,444 998,469 (1%) 0% 2.0 19,266 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.01 per share. 13 Oct 2023 9,585 989,025 (1%) 0% 2.0 19,266 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.92 per share. 29 Sep 2023 10,035 979,440 (1%) 0% 1.9 19,267 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 26 Sep 2023 1,466,204 9,466,495 (16%) 2% 5 7,331,020 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 26 Sep 2023 170,000 9,635,495 (16%) 0% 5 850,000 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2023 200,000 0 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2023 200,000 0 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2023 200,000 0 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2023 170,000 330,000 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2023 1,466,204 0 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. 26 Sep 2023 200,000 10,235,495 (17%) 0% 3 600,000 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share. 26 Sep 2023 200,000 10,035,495 (17%) 0% 3.3 652,000 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. 26 Sep 2023 200,000 9,835,495 (17%) 0% 3 600,000 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.76 per share. 15 Sep 2023 10,947 969,405 (1%) 0% 1.8 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.75 per share. 31 Aug 2023 11,010 958,458 (1%) 0% 1.8 19,268 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.60 per share. 15 Aug 2023 12,042 947,448 (1%) 0% 1.6 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.50 per share. 31 Jul 2023 12,844 935,406 (1%) 0% 1.5 19,266 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 1.79 per share. 19 Jul 2023 1,598 48,813 (0%) 0% 1.8 2,854 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.63 per share. 14 Jul 2023 11,820 922,562 (1%) 0% 1.6 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.44 per share. 30 Jun 2023 13,380 910 (0%) 0% 1.4 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.46 per share. 15 Jun 2023 13,196 897,362 (1%) 0% 1.5 19,266 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.57 per share. 31 May 2023 12,272 884,166 (1%) 0% 1.6 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.64 per share. 15 May 2023 11,748 871,894 (1%) 0% 1.6 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.76 per share. 28 Apr 2023 10,947 860,146 (1%) 0% 1.8 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.01 per share. 14 Apr 2023 9,585 849,199 (1%) 0% 2.0 19,266 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.10 per share. 31 Mar 2023 9,175 839,614 (1%) 0% 2.1 19,268 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.90 per share. 15 Mar 2023 10,140 830,439 (1%) 0% 1.9 19,266 Common Stock
Joel Lewis Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.07 per share. 28 Feb 2023 75,529 820,299 (1%) 0% 2.1 156,345 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.07 per share. 28 Feb 2023 9,308 895,828 (1%) 0% 2.1 19,268 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 1.59 per share. 21 Feb 2023 1,000 47,215 (0%) 0% 1.6 1,591 Common Stock
Joel Lewis Director, President and CEO Purchase of securities on an exchange or from another person at price $ 1.52 per share. 16 Feb 2023 1,000 1,000 (0%) 0% 1.5 1,520 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.44 per share. 15 Feb 2023 13,380 886,520 (1%) 0% 1.4 19,267 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.43 per share. 07 Feb 2023 143,836 873,140 (1%) 0% 1.4 205,685 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.16 per share. 31 Jan 2023 15,086 729,304 (1%) 0% 1.2 17,500 Common Stock
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 50,000 50,000 - - Stock Option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Harold H. Shlevin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 50,000 50,000 - - Stock Option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.11 per share. 26 Jan 2023 36,036 7,999,291 (14%) 0% 1.1 40,000 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 70,000 70,000 - - Stock Option (right to buy)
Elissa J. Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Richard A. Zordani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 1.11 per share. 25 Jan 2023 1,300 46,215 (0%) 0% 1.1 1,443 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.14 per share. 13 Jan 2023 15,351 714,218 (1%) 0% 1.1 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.13 per share. 30 Dec 2022 15,487 698,867 (1%) 0% 1.1 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.16 per share. 15 Dec 2022 15,086 683,380 (1%) 0% 1.2 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.27 per share. 30 Nov 2022 13,780 668,294 (1%) 0% 1.3 17,501 Common Stock
Jack W. Callicutt Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.32 per share. 17 Nov 2022 4,000 7,614 (0%) 0% 1.3 5,280 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.24 per share. 15 Nov 2022 14,113 654,514 (1%) 0% 1.2 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.38 per share. 31 Oct 2022 12,681 640,401 (1%) 0% 1.4 17,500 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 1.41 per share. 28 Oct 2022 10,000 75,000 (0%) 0% 1.4 14,100 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.62 per share. 14 Oct 2022 10,802 627,720 (1%) 0% 1.6 17,499 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.63 per share. 30 Sep 2022 10,736 616,918 (1%) 0% 1.6 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.79 per share. 15 Sep 2022 9,777 606,182 (1%) 0% 1.8 17,501 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.90 per share. 31 Aug 2022 9,211 596,405 (1%) 0% 1.9 17,501 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.18 per share. 15 Aug 2022 8,028 587,194 (1%) 0% 2.2 17,501 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.26 per share. 29 Jul 2022 7,743 552,139 (0%) 0% 2.3 17,499 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 2.50 per share. 28 Jul 2022 5,000 29,583 (0%) 0% 2.5 12,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.65 per share. 15 Jul 2022 10,606 544,396 (0%) 0% 1.7 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.31 per share. 30 Jun 2022 13,359 533,790 (0%) 0% 1.3 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.29 per share. 15 Jun 2022 13,780 520,431 (0%) 0% 1.3 17,776 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.29 per share. 31 May 2022 13,566 506,651 (0%) 0% 1.3 17,500 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 1.33 per share. 19 May 2022 5,000 65,000 (0%) 0% 1.3 6,650 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.36 per share. 13 May 2022 12,868 493,085 (0%) 0% 1.4 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.55 per share. 29 Apr 2022 11,290 480,217 (0%) 0% 1.6 17,500 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 1.71 per share. 18 Apr 2022 5,000 60,000 (0%) 0% 1.7 8,550 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.74 per share. 15 Apr 2022 10,057 468,927 (0%) 0% 1.7 17,499 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 1.60 per share. 04 Apr 2022 5,000 24,583 (0%) 0% 1.6 8,025 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.61 per share. 31 Mar 2022 10,870 458,870 (0%) 0% 1.6 17,501 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.74 per share. 15 Mar 2022 10,057 448,000 (0%) 0% 1.7 17,499 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.87 per share. 28 Feb 2022 9,358 437 (0%) 0% 1.9 17,499 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.07 per share. 15 Feb 2022 8,454 428,585 (0%) 0% 2.1 17,500 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.93 per share. 31 Jan 2022 112,263 420,131 (0%) 0% 1.9 216,668 Common Stock
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 50,000 50,000 - - Stock Option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Harold H. Shlevin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 50,000 50,000 - - Stock Option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.98 per share. 24 Jan 2022 17,677 7,936,677 (13%) 0% 2.0 35,000 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 70,000 70,000 - - Stock Option (right to buy)
Elissa J. Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Richard A. Zordani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 40,000 40,000 - - Stock Option (right to buy)
Elissa J. Schwartz Director Purchase of securities on an exchange or from another person at price $ 2.00 per share. 21 Jan 2022 1,000 1,000 (0%) 0% 2 2,000 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 1.96 per share. 19 Jan 2022 5,000 55,000 (0%) 0% 2.0 9,806 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.02 per share. 14 Jan 2022 8,251 307,868 (0%) 0% 2.0 16,667 Common Stock
Richard A. Zordani Director Purchase of securities on an exchange or from another person at price $ 2.02 per share. 14 Jan 2022 5,000 19,583 (0%) 0% 2.0 10,100 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.28 per share. 15 Dec 2021 5,000 50,000 (0%) 0% 2.3 11,400 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.25 per share. 15 Dec 2021 7,407 291,565 (0%) 0% 2.3 16,666 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.34 per share. 06 Dec 2021 5,000 45,000 (0%) 0% 2.3 11,700 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.63 per share. 30 Nov 2021 6,337 284,158 (0%) 0% 2.6 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.86 per share. 15 Nov 2021 5,828 277,821 (0%) 0% 2.9 16,668 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.17 per share. 29 Oct 2021 2,000 40,000 (0%) 0% 3.2 6,340 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.17 per share. 29 Oct 2021 5,258 271,993 (0%) 0% 3.2 16,668 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.19 per share. 21 Oct 2021 2,000 38,000 (0%) 0% 3.2 6,380 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.37 per share. 19 Oct 2021 3,000 36,000 (0%) 0% 3.4 10,107 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.37 per share. 15 Oct 2021 4,946 266,735 (0%) 0% 3.4 16,668 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.88 per share. 30 Sep 2021 4,296 261,789 (0%) 0% 3.9 16,668 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.88 per share. 23 Sep 2021 3,000 33,000 (0%) 0% 3.9 11,631 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Sep 2021 1,157,407 10,000,000 - - Convertible Note
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.73 per share. 15 Sep 2021 4,468 257,493 (0%) 0% 3.7 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.93 per share. 31 Aug 2021 4,241 253,025 (0%) 0% 3.9 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.38 per share. 13 Aug 2021 4,931 248,784 (0%) 0% 3.4 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.75 per share. 30 Jul 2021 6,061 243,853 (0%) 0% 2.8 16,668 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.59 per share. 15 Jul 2021 6,435 237,792 (0%) 0% 2.6 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.20 per share. 30 Jun 2021 5,208 231,357 (0%) 0% 3.2 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.50 per share. 15 Jun 2021 4,762 226,149 (0%) 0% 3.5 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.97 per share. 01 Jun 2021 4,198 221,387 (0%) 0% 4.0 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 4.23 per share. 14 May 2021 3,940 217,189 (0%) 0% 4.2 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 4.42 per share. 30 Apr 2021 3,771 213,249 (0%) 0% 4.4 16,668 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2021 2,000,000 10,000,000 - - Convertible Note
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.23 per share. 15 Apr 2021 7,474 209,478 (0%) 0% 2.2 16,667 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.04 per share. 05 Apr 2021 5,000 30,000 (0%) 0% 2.0 10,200 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.17 per share. 31 Mar 2021 7,680 202,004 (0%) 0% 2.2 16,666 Common Stock
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 50,000 50,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 100,000 100,000 - - Stock option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Harold H. Shlevin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Harold H. Shlevin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 100,000 100,000 - - Stock option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 50,000 50,000 - - Stock option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Joel Lewis Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Joel Lewis Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 140,000 140,000 - - Stock option (right to buy)
Elissa J. Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Elissa J. Schwartz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Richard A. Zordani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 40,000 40,000 - - Stock option (right to buy)
Richard A. Zordani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 70,000 70,000 - - Stock option (right to buy)
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.50 per share. 15 Mar 2021 6,667 194,324 (0%) 0% 2.5 16,668 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.22 per share. 05 Mar 2021 27,027 214,684 (0%) 0% 2.2 60,000 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.24 per share. 26 Feb 2021 7,440 187,657 (0%) 0% 2.2 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.49 per share. 15 Feb 2021 6,693 180,217 (0%) 0% 2.5 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.96 per share. 29 Jan 2021 8,503 173,524 (0%) 0% 2.0 16,666 Common Stock
Gilbert F. Amelio Director Sale of securities on an exchange or to another person at price $ 2.17 per share. 11 Jan 2021 60,000 60,614 (0%) 0% 2.2 130,200 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.52 per share. 15 Dec 2020 6,614 149,971 (0%) 0% 2.5 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.60 per share. 30 Nov 2020 6,410 143,357 (0%) 0% 2.6 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.75 per share. 13 Nov 2020 6,061 136,947 (0%) 0% 2.8 16,668 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.54 per share. 30 Oct 2020 6,562 130,886 (0%) 0% 2.5 16,667 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.87 per share. 15 Oct 2020 5,807 124,324 (0%) 0% 2.9 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.67 per share. 30 Sep 2020 6,242 118,517 (0%) 0% 2.7 16,666 Common Stock
Joel Lewis Director, President and CEO Grant, award, or other acquisition of securities at price $ 2.93 per share. 15 Sep 2020 5,171 112,275 (0%) 0% 2.9 15,151 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 2.57 per share. 04 Sep 2020 5,000 25,000 (0%) 0% 2.6 12,848 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.55 per share. 04 Sep 2020 10,000 7,893,191 (13%) 0% 2.6 25,500 Common Stock
Joel Lewis Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2020 250,000 250,000 - - Stock option (right to buy)
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 1.64 per share. 19 Mar 2020 6,000 20,000 (0%) 0% 1.6 9,844 Common Stock
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 300,000 300,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2020 46,875 0 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 13 Feb 2020 46,875 7,864,553 (13%) 0% 2.4 112,031 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. 13 Feb 2020 18,638 7,883,191 (13%) 0% 4.7 87,971 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2020 18,638 21,362 - - Stock option (right to buy)
Joel Lewis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2020 8,000 54,250 - - Stock option (right to buy)
Joel Lewis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 09 Feb 2020 8,000 107,104 (0%) 0% 2.4 19,120 Common Stock
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 30,000 30,000 - - Stock option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 40,000 40,000 - - Stock option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 40,000 40,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 50,000 50,000 - - Stock option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 30,000 30,000 - - Stock option (right to buy)
Harold H. Shlevin Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 70,000 70,000 - - Stock option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 45,000 45,000 - - Stock option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 30,000 30,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 45,000 45,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 2.86 per share. 09 Jan 2020 12,238 7,817,678 (13%) 0% 2.9 35,001 Common Stock
Joel Lewis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2020 40,000 40,000 - - Stock option (right to buy)
Joel Lewis Director Grant, award, or other acquisition of securities at price $ 2.86 per share. 09 Jan 2020 20,455 99,104 (0%) 0% 2.9 58,501 Common Stock
James C. Czirr Director Other type of transaction at price $ 0.00 per share. 31 Dec 2019 125,000 767,616 (1%) 0% - Common Stock
James C. Czirr Director Other type of transaction at price $ 6.00 per share. 31 Dec 2019 1,000 892,616 (1%) 0% 6 6,000 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.36 per share. 15 Nov 2019 3,000 14,000 (0%) 0% 3.4 10,076 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 3.71 per share. 06 Sep 2019 1,290 11,000 (0%) 0% 3.7 4,786 Common Stock
Gilbert F. Amelio Director Sale of securities on an exchange or to another person at price $ 3.30 per share. 05 Sep 2019 30,000 124,614 (0%) 0% 3.3 99,000 Common Stock
Harold H. Shlevin Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2019 8,706 29,294 - - Stock option (right to buy)
Harold H. Shlevin Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. 04 Jun 2019 8,706 8,706 (0%) 0% 1.4 11,927 Common Stock
Gilbert S. Omenn Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 18,578 66,769 (0%) 0% 4.3 79,514 Common Stock
Gilbert S. Omenn Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 61,929 61,929 - - Common Stock Purchase Warrant (right to buy)
Jack W. Callicutt Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 2,354 3,614 (0%) 0% 4.3 10,075 Common Stock
Jack W. Callicutt Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 7,847 7,847 - - Common Stock Purchase Warrant (right to buy)
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 7,710 9,710 (0%) 0% 4.3 32,999 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 25,700 25,700 - - Common Stock Purchase Warrant (right to buy)
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 4,753 4,753 - - Common Stock Purchase Warrant (right to buy)
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 1,426 23,469 (0%) 0% 4.3 6,103 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 3,033 44,415 (0%) 0% 4.3 12,981 Common Stock
Kary Eldred Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 10,110 10,110 - - Common Stock Purchase Warrant (right to buy)
Joel Lewis Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 May 2019 42,831 42,831 - - Common Stock Purchase Warrant (right to buy)
Joel Lewis Director Purchase of securities on an exchange or from another person at price $ 4.28 per share. 31 May 2019 12,849 78,649 (0%) 0% 4.3 54,994 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.28 per share. 29 May 2019 4,672,896 7,801,385 (13%) 8% 4.3 19,999,995 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 29 May 2019 500,000 3,128,489 (5%) 0% 5 2,500,000 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.28 per share. 29 May 2019 7,710 27,710 (0%) 0% 4.3 32,999 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2019 15,576,322 15,576,322 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 May 2019 500,000 966,204 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2019 25,700 25,700 - - Common Stock Purchase Warrant (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.82 per share. 09 Apr 2019 20,700 2,628,489 (4%) 0% 4.8 99,851 Common Stock
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 4.73 per share. 05 Apr 2019 500 2,000 (0%) 0% 4.7 2,365 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.81 per share. 05 Apr 2019 21,000 2,607,789 (4%) 0% 4.8 100,972 Common Stock
Joel Lewis Director Purchase of securities on an exchange or from another person at price $ 4.82 per share. 05 Apr 2019 667 65,800 (0%) 0% 4.8 3,214 Common Stock
Marc Rubin Director Sale of securities on an exchange or to another person at price $ 6.02 per share. 21 Feb 2019 859 13,581 (0%) 0% 6.0 5,175 Common Stock
Marc Rubin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 21 Feb 2019 859 14,440 (0%) 0% 2.4 2,053 Common Stock
Marc Rubin Director Sale of securities on an exchange or to another person at price $ 6.02 per share. 21 Feb 2019 43,326 13,581 (0%) 0% 6.0 261,026 Common Stock
Marc Rubin Director Sale of securities on an exchange or to another person at price $ 6.00 per share. 21 Feb 2019 7,000 13,581 (0%) 0% 6 42,000 Common Stock
Marc Rubin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 21 Feb 2019 43,326 56,907 (0%) 0% 2.4 103,549 Common Stock
Marc Rubin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2019 859 33,065 - - Stock option (right to buy)
Marc Rubin Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2019 43,326 33,924 - - Stock option (right to buy)
Kevin D. Freeman Director Purchase of securities on an exchange or from another person at price $ 4.29 per share. 08 Feb 2019 1,500 1,500 (0%) 0% 4.3 6,428 Common Stock
Joel Lewis Director Purchase of securities on an exchange or from another person at price $ 4.48 per share. 07 Feb 2019 1,000 65,133 (0%) 0% 4.5 4,484 Common Stock
Gilbert F. Amelio Director Sale of securities on an exchange or to another person at price $ 5.00 per share. 30 Jan 2019 13,047 154,614 (0%) 0% 5 65,235 Common Stock
Gilbert F. Amelio Director Sale of securities on an exchange or to another person at price $ 5.00 per share. 30 Jan 2019 16,953 167,661 (0%) 0% 5 84,765 Common Stock
Joel Lewis Director Purchase of securities on an exchange or from another person at price $ 4.80 per share. 29 Jan 2019 1,000 64,133 (0%) 0% 4.8 4,805 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.87 per share. 28 Jan 2019 48,500 2,586,789 (4%) 0% 4.9 236,244 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.77 per share. 28 Jan 2019 3,000 2,538,289 (4%) 0% 4.8 14,315 Common Stock
Gilbert F. Amelio Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.75 per share. 21 Jan 2019 7,776 153,685 (0%) 0% 4.8 36,936 Common Stock
Gilbert F. Amelio Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jan 2019 62,250 0 - - Stock option (right to buy)
Gilbert F. Amelio Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jan 2019 41,500 0 - - Stock option (right to buy)
Gilbert F. Amelio Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.75 per share. 21 Jan 2019 31,322 184,614 (0%) 0% 4.8 148,780 Common Stock
Gilbert F. Amelio Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 21 Jan 2019 62,250 215,935 (0%) 0% 2.4 148,778 Common Stock
Gilbert F. Amelio Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.89 per share. 21 Jan 2019 41,500 161,461 (0%) 0% 0.9 36,935 Common Stock
James C. Czirr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 25,000 25,000 - - Stock option (right to buy)
Gilbert S. Omenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 35,000 35,000 - - Stock option (right to buy)
Gilbert F. Amelio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 35,000 35,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 50,000 50,000 - - Stock option (right to buy)
Marc Rubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 25,000 25,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 70,000 70,000 - - Stock option (right to buy)
Kevin D. Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 40,000 40,000 - - Stock option (right to buy)
Kary Eldred Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 25,000 25,000 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 4.72 per share. 16 Jan 2019 7,415 2,535,289 (4%) 0% 4.7 34,999 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 40,000 40,000 - - Stock option (right to buy)
Joel Lewis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 35,000 35,000 - - Stock option (right to buy)
Joel Lewis Director Grant, award, or other acquisition of securities at price $ 4.72 per share. 16 Jan 2019 11,653 63,133 (0%) 0% 4.7 55,002 Common Stock
Stephen Shulman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2019 25,000 25,000 - - Stock option (right to buy)
James C. Czirr None Other type of transaction at price $ 6.00 per share. 31 Dec 2018 1,000 890,630 (2%) 0% 6 6,000 Common Stock
James C. Czirr None Other type of transaction at price $ 6.00 per share. 31 Dec 2018 1,000 891,630 (2%) 0% 6 6,000 Common Stock
Kary Eldred None Purchase of securities on an exchange or from another person at price $ 6.10 per share. 25 Sep 2018 2,000 41,382 (0%) 0% 6.1 12,200 Common Stock
Gilbert S. Omenn None Sale of securities on an exchange or to another person at price $ 6.03 per share. 07 Sep 2018 11,000 56,561 (0%) 0% 6.0 66,365 Common Stock
Gilbert S. Omenn None Sale of securities on an exchange or to another person at price $ 6.00 per share. 07 Sep 2018 8,370 48,191 (0%) 0% 6 50,220 Common Stock
Marc Rubin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Sep 2018 6,000 16,500 - - Stock option (right to buy)
Marc Rubin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Sep 2018 6,000 32,481 (0%) 0% 0 Common Stock
Marc Rubin None Sale of securities on an exchange or to another person at price $ 6.58 per share. 04 Sep 2018 11,900 20,581 (0%) 0% 6.6 78,256 Common Stock
Marc Rubin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Aug 2018 29,000 22,500 - - Stock option (right to buy)
Marc Rubin None Sale of securities on an exchange or to another person at price $ 6.08 per share. 30 Aug 2018 58,100 26,481 (0%) 0% 6.1 353,312 Common Stock
Marc Rubin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Aug 2018 29,000 84,581 (0%) 0% 0 Common Stock
Joel Lewis None Purchase of securities on an exchange or from another person at price $ 7.06 per share. 25 Jun 2018 1,000 51,480 (0%) 0% 7.1 7,058 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. 19 Jun 2018 102,733 103,993 (0%) 0% 4.4 453,053 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 26,000 0 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 97,267 0 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 8.08 per share. 19 Jun 2018 97,267 1,260 (0%) 0% 8.1 786,034 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. 19 Jun 2018 97,267 98,527 (0%) 0% 4.4 428,947 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 9.01 per share. 19 Jun 2018 128,733 1,260 (0%) 0% 9.0 1,159,987 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. 19 Jun 2018 26,000 129,993 (0%) 0% 3.5 89,700 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 102,733 97,267 - - Stock option (right to buy)
James C. Czirr None Sale of securities on an exchange or to another person at price $ 9.06 per share. 14 Jun 2018 60,000 2,649,786 (7%) 0% 9.1 543,600 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 8.47 per share. 14 Jun 2018 15,475 2,709,786 (7%) 0% 8.5 131,073 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 7.99 per share. 14 Jun 2018 31,860 2,769,786 (7%) 0% 8.0 254,561 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 8.48 per share. 14 Jun 2018 44,525 2,725,261 (7%) 0% 8.5 377,572 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 6.59 per share. 13 Jun 2018 60,000 2,949,786 (7%) 0% 6.6 395,400 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 7.09 per share. 13 Jun 2018 60,000 2,889,786 (7%) 0% 7.1 425,400 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 7.47 per share. 13 Jun 2018 60,000 2,829,786 (7%) 0% 7.5 448,200 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 7.97 per share. 13 Jun 2018 28,140 2,801,646 (7%) 0% 8.0 224,276 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. 13 Jun 2018 9,294 10,554 (0%) 0% 1.4 12,733 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 7.01 per share. 13 Jun 2018 9,294 1,260 (0%) 0% 7.0 65,167 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2018 9,294 8,706 - - Stock option (right to buy)
Peter G. Traber President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2018 100,000 50,000 - - Stock option (right to buy)
Peter G. Traber President & CEO Sale of securities on an exchange or to another person at price $ 7.51 per share. 13 Jun 2018 100,000 107,333 (0%) 0% 7.5 751,000 Common Stock
Peter G. Traber President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 13 Jun 2018 100,000 207,333 (0%) 0% 0.9 87,000 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.79 per share. 12 Jun 2018 30,918 0 (0%) 0% 7.8 240,916 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2018 25,544 30,918 (0%) 0% 0 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2018 25,544 12,456 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.50 per share. 12 Jun 2018 12,780 5,374 (0%) 0% 6.5 83,070 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 5.64 per share. 08 Jun 2018 50,000 3,069,786 (8%) 0% 5.6 282,000 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 6.08 per share. 08 Jun 2018 60,000 3,009,786 (7%) 0% 6.1 364,800 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 6.38 per share. 08 Jun 2018 20,000 1,260 (0%) 0% 6.4 127,500 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2018 20,000 18,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2018 100,000 0 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 08 Jun 2018 100,000 101,260 (0%) 0% 0.9 87,000 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.75 per share. 08 Jun 2018 100,000 1,260 (0%) 0% 5.8 575,000 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. 08 Jun 2018 20,000 21,260 (0%) 0% 1.4 27,400 Common Stock
Peter G. Traber President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2018 70,000 150,000 - - Stock option (right to buy)
Peter G. Traber President & CEO Sale of securities on an exchange or to another person at price $ 5.86 per share. 08 Jun 2018 70,000 107,333 (0%) 0% 5.9 409,997 Common Stock
Peter G. Traber President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 08 Jun 2018 70,000 177,333 (0%) 0% 0.9 60,900 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2018 29,294 8,706 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2018 50,000 0 - - Stock option (right to buy)
Harold H. Shlevin Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2018 35,000 35,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 08 Jun 2018 50,000 103,914 (0%) 0% 0.9 43,500 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. 08 Jun 2018 29,294 184,099 (0%) 0% 1.4 40,133 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.77 per share. 08 Jun 2018 104,294 28,914 (0%) 0% 5.8 602,048 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.50 per share. 08 Jun 2018 10,760 18,154 (0%) 0% 6.5 69,940 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2018 75,190 0 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 06 Jun 2018 4,180 58,094 (0%) 0% 2.3 9,698 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 06 Jun 2018 4,898 62,992 (0%) 0% 0.9 4,261 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.15 per share. 06 Jun 2018 9,078 53,914 (0%) 0% 5.2 46,752 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 06 Jun 2018 75,190 129,104 (0%) 0% 2.3 174,441 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 06 Jun 2018 25,701 154,805 (0%) 0% 0.9 22,360 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.21 per share. 06 Jun 2018 100,891 53,914 (0%) 0% 5.2 525,269 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2018 4,180 75,190 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2018 4,898 75,701 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jun 2018 25,701 50,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2018 5,500 85,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2018 5,407 84,893 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2018 5,630 79,370 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.16 per share. 04 Jun 2018 9,924 53,914 (0%) 0% 5.2 51,183 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2018 4,294 80,599 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 04 Jun 2018 5,500 59,414 (0%) 0% 2.3 12,760 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 04 Jun 2018 5,407 64,821 (0%) 0% 0.9 4,704 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.15 per share. 04 Jun 2018 10,907 53,914 (0%) 0% 5.2 56,173 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 04 Jun 2018 5,630 65,044 (0%) 0% 2.3 13,062 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 04 Jun 2018 4,294 69,338 (0%) 0% 0.9 3,736 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 5.13 per share. 01 Jun 2018 8,093 3,119,786 (8%) 0% 5.1 41,517 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 5.12 per share. 01 Jun 2018 41,907 3,161,693 (8%) 0% 5.1 214,564 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 31 May 2018 46,651 1,260 (0%) 0% 5 233,255 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2018 46,651 100,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 31 May 2018 46,651 47,911 (0%) 0% 0.9 40,586 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 31 May 2018 50,000 103,914 (0%) 0% 2.3 116,000 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.10 per share. 31 May 2018 69,200 53,914 (0%) 0% 5.1 352,920 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 31 May 2018 59,700 123,114 (0%) 0% 0.9 51,939 Common Stock
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2018 50,000 100,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2018 9,500 90,500 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 May 2018 59,700 90,300 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.32 per share. 31 May 2018 9,500 63,414 (0%) 0% 2.3 22,040 Common Stock
Harold H. Shlevin Chief Operating Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 31 May 2018 50,000 53,914 (0%) 0% 5 250,000 Common Stock
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 90,000 90,000 - - Stock option (right to buy)
Peter G. Traber President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 125,000 125,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 90,000 90,000 - - Stock option (right to buy)
Kary Eldred None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 46,875 46,875 - - Stock option (right to buy)
Theodore H. Zucconi None Sale of securities on an exchange or to another person at price $ 3.58 per share. 16 Apr 2018 4,000 1,083 (0%) 0% 3.6 14,320 Common Stock
Theodore H. Zucconi None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2018 4,000 27,250 - - Stock option (right to buy)
Theodore H. Zucconi None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.89 per share. 16 Apr 2018 4,000 5,083 (0%) 0% 0.9 3,560 Common Stock
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2018 3,349 146,651 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. 04 Apr 2018 3,349 4,609 (0%) 0% 0.9 2,914 Common Stock
Jack W. Callicutt Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 04 Apr 2018 3,349 1,260 (0%) 0% 5 16,745 Common Stock
Kevin D. Freeman None Purchase of securities on an exchange or from another person at price $ 4.10 per share. 01 Feb 2018 2,000 16,000 (0%) 0% 4.1 8,191 Common Stock
Kevin D. Freeman None Purchase of securities on an exchange or from another person at price $ 4.10 per share. 01 Feb 2018 2,000 16,000 (0%) 0% 4.1 8,191 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 5.45 per share. 25 Jan 2018 205,144 3,160,284 (8%) 0% 5.5 1,118,035 Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 5.35 per share. 25 Jan 2018 39,300 3,120,984 (8%) 0% 5.4 210,255 Common Stock
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2018 90,000 90,000 - - Stock option (right to buy)
Peter G. Traber President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2018 125,000 125,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2018 90,000 90,000 - - Stock option (right to buy)
James C. Czirr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 46,875 46,875 - - Stock option (right to buy)
Gilbert S. Omenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 62,250 62,250 - - Stock option (right to buy)
Gilbert F. Amelio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 62,250 62,250 - - Stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 77,250 77,250 - - Stock option (right to buy)
Theodore H. Zucconi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 46,875 46,875 - - Stock option (right to buy)
Kevin D. Freeman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 46,875 46,875 - - Stock option (right to buy)
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 2.39 per share. 14 Dec 2017 14,644 2,524,553 (7%) 0% 2.4 34,999 Common Stock
Richard E. Uihlein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 46,875 46,875 - - Stock option (right to buy)
Joel Lewis None Grant, award, or other acquisition of securities at price $ 2.39 per share. 14 Dec 2017 23,013 50,880 (0%) 0% 2.4 55,001 Common Stock
Joel Lewis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 62,250 62,250 - - Stock option (right to buy)
Stephen Shulman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2017 46,875 46,875 - - Stock option (right to buy)
Marc Rubin None Purchase of securities on an exchange or from another person at price $ 1.85 per share. 08 Dec 2017 7,000 55,581 (0%) 0% 1.9 12,972 Common Stock
Kevin D. Freeman None Purchase of securities on an exchange or from another person at price $ 1.63 per share. 07 Dec 2017 8,000 8,000 (0%) 0% 1.6 13,005 Common Stock
Kevin D. Freeman None Purchase of securities on an exchange or from another person at price $ 1.64 per share. 07 Dec 2017 400 28,043 (0%) 0% 1.6 657 Common Stock
James C. Czirr None Other type of transaction at price $ 6.00 per share. 30 Sep 2017 1,000 889,630 (2%) 0% 6 6,000 Common Stock
James C. Czirr None Other type of transaction at price $ 1.93 per share. 30 Sep 2017 119,129 3,254,279 (9%) 0% 1.9 229,919 Common Stock
James C. Czirr None Other type of transaction at price $ 2.07 per share. 30 Sep 2017 111,149 3,365,428 (9%) 0% 2.1 230,078 Common Stock
Theodore H. Zucconi None Purchase of securities on an exchange or from another person at price $ 2.27 per share. 23 May 2017 1,000 1,083 (0%) 0% 2.3 2,270 Common stock
James C. Czirr None Other type of transaction at price $ 1.98 per share. 31 Mar 2017 116,151 3,039,945 (8%) 0% 2.0 229,979 Common Stock
James C. Czirr None Other type of transaction at price $ 6.00 per share. 31 Mar 2017 1,000 888,630 (2%) 0% 6 6,000 Common Stock
James C. Czirr None Other type of transaction at price $ 2.42 per share. 31 Mar 2017 95,205 3,135,150 (8%) 0% 2.4 230,396 Common Stock
Theodore H. Zucconi None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jan 2017 2,299 123 - - Warrants (right to buy)
Theodore H. Zucconi None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jan 2017 85 38 - - Warrants (right to buy)
James C. Czirr None Other type of transaction at price $ 0.00 per share. 31 Dec 2016 211,876 2,923,794 - - Common Stock
James C. Czirr None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2016 1,008,000 2,508,000 - - Series B-3 Convertible Preferred Stock
James C. Czirr None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2016 1 3 - - Series B-3 Warrant
James C. Czirr None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2016 1 6 - - Lock-Up Warrant
James C. Czirr None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2016 1 7 - - Lock-Up Warrant
Gilbert S. Omenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 41,500 41,500 - - Stock option (right to buy)
James C. Czirr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 31,250 31,250 - - Stock option (right to buy)
Gilbert F. Amelio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 41,500 41,500 - - Stock option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 51,500 51,500 - - Stock option (right to buy)
Steven Prelack None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 41,500 41,500 - - Stock option (right to buy)
Theodore H. Zucconi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 31,250 31,250 - - Stock option (right to buy)
Arthur R. Greenberg None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 31,250 31,250 - - Stock option (right to buy)
Kevin D. Freeman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 31,250 31,250 - - Stock option (right to buy)
John Mauldin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2016 31,250 31,250 - - Stock option (right to buy)
Peter G. Traber Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2016 220,000 220,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2016 150,000 150,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2016 150,000 150,000 - - Stock option (right to buy)
James C. Czirr None Other type of transaction at price $ 0.00 per share. 10 Nov 2016 9,663 3,186,452 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 10 Nov 2016 17,096 3,169,356 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Sep 2016 92,451 3,377,359 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Sep 2016 164,110 3,213,249 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Sep 2016 484,036 2,729,213 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Sep 2016 17,295 2,711,918 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Jun 2016 124,524 3,385,221 - - Common Stock
James C. Czirr None Other type of transaction at price $ 0.00 per share. 30 Jun 2016 84,589 3,469,810 - - Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 33,100 3,271,909 - - Common Stock
James C. Czirr None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 11,212 3,260,697 - - Common Stock
Peter G. Traber Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 134,000 134,000 - - Stock option (right to buy)
Jack W. Callicutt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 38,000 38,000 - - Stock option (right to buy)
Harold H. Shlevin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2016 38,000 38,000 - - Stock option (right to buy)
Arthur R. Greenberg None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jan 2016 1,666 109,445 - - Common Stock
Gilbert F. Amelio None Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Nov 2015 100 119,961 - - Common Stock
Peter G. Traber Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Aug 2015 2,000 107,333 - - Common Stock
Peter G. Traber President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Jun 2015 4,000 105,333 - - Common Stock
Kevin D. Freeman None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Jun 2015 2,083 2,083 - - Common Stock
Gilbert S. Omenn None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 28,323 0 - - Stock Option (right to buy)
Gilbert S. Omenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 25,934 67,561 - - Common Stock
Gilbert S. Omenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 11,112 40,121 - - Common Stock
Gilbert S. Omenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 1,506 41,627 - - Common Stock
Paul Pressler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 1,784 11,284 - - Common Stock
Paul Pressler None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 16,714 0 - - Stock Option (right to buy)
Paul Pressler None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 25,483 36,767 - - Common Stock
Paul Pressler None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 14,815 0 - - Stock Option (right to buy)
Gilbert F. Amelio None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 7,408 0 - - Stock Option (right to buy)
Gilbert F. Amelio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 1,054 104,140 - - Common Stock
Gilbert F. Amelio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 11,112 103,086 - - Common Stock
Gilbert F. Amelio None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 6,780 0 - - Stock Option (right to buy)
Gilbert F. Amelio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 15,921 120,061 - - Common Stock
Gilbert F. Amelio None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 10,034 0 - - Stock Option (right to buy)
Marc Rubin None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2015 16,495 0 - - Stock Option (right to buy)
Marc Rubin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 2,768 48,581 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters